Moshkevich Solomon has filed a notice with the SEC to sell 3,000 shares of Natera, Inc., a move that underscores the executive's ongoing management of his equity stake in the company. This filing, dated November 2, 2026, reveals a significant transaction in the medical laboratories sector, where Natera operates.

Natera, Inc. is a prominent player in the medical laboratories industry, focusing on genetic testing and related services. The company is incorporated in Delaware and has its headquarters in Austin, Texas. It trades on the NASDAQ under the SEC file number 001-37478.

The filing notes that Solomon Moshkevich, an officer at Natera, will sell the shares with an aggregate market value of approximately $1,233,379.80. The shares were acquired as restricted stock on May 25, 2026, and the sale is part of a broader trend of executives liquidating portions of their stock holdings. Moshkevich has been active in the market, having sold shares in previous months, including 1,162 shares on October 29, 2026, for gross proceeds of $495,407.54, and 1,010 shares on October 27, 2026, for $410,060.00.

These transactions may impact stakeholders, including shareholders and potential investors, as they reflect the confidence of company executives in the stock's future performance. The filing does not specify what actions will follow this sale, leaving some uncertainty about Moshkevich's future plans regarding his remaining shares.

Details were not available in the SEC filing regarding any upcoming votes or additional filings related to this transaction.